Searched for
FOREIGN DRUG MAKERS
Bio Medica Laboratories shares to debut today. Here's what GMP suggests ahead of listingBio Medica Laboratories' shares are set to list on the NSE SME platform amidst weak grey market sentiment, with the IPO currently trading a...- Trump family deal spree could open door for future presidents to profit from officeIn a striking maneuver, President Donald Trump's family business is broadening its horizons internationally while tapping into the burgeoni...
- Pfizer likely to get indemnity in IndiaThe government is likely to indemnify Pfizer Inc against future liabilities arising from adverse after-effects of its Covid-19 jabs, paving...
- Drug makers may have to pay 5 times more for pharma importsThe ministry is once again mulling a hike in fees for several regulatory submissions for foreign drug makers, said two senior health minist...
- Foreign pharma firms make pitch for easing FDI normsAhead of US President Barack Obama’s visit, OPPI has urged govt to allow inclusion of non-complete clauses when it comes to M&As.
- Foreign drug makers urge government to review IPR think tankA similar point has also been raised by the US biotech groupings PhRMA and BIO in their submissions to the US Trade Representative's office.
- US generic drug fee relief plan may benefit Indian companiesAmerican health regulator FDA could consider bringing some relief in payment of fees to small generic drug makers, including those from Ind...
- New caveat in drug FDI policy worries MNCsValuations of Indian pharmaceutical companies may drop with the government deciding to bar non-compete clauses in takeovers by foreign comp...
- More curbs on FDI in pharma likelyDraft Cabinet note for investment in drug facilities defined “critical” on the approval route, seeks to cut FDI limit to 49%.
- BJP voices concern in Rajya Sabha over foreign take-over of Indian drug firmsA BJP MP said Rs 40,000 crore worth drugs were exported to many countries and foreign firms were out to take control over it by buying all ...
- Law Ministry favours giving CCI power to vet pharma buys by MNCs and foreign investorsThe law ministry has favoured widening of the CCI's mandate to give it the power to vet acquisitions of local pharma cos by MNCs & foreign ...
- Pricing of imported drugs under regulatory scannerNPPA has initiated a process to end the freedom enjoyed by drug makers to fix the retail price of their imported medicines.
- FIPB to take up 10 pharma FDI proposals on FridayForeign investment approval authority may take a call on proposals of 10 foreign drug makers and investors to buy stakes in local drug make...
- Supreme Court defers Novartis' patent appeal to September 11Supreme Court on Wednesday deferred Swiss company Novartis' case against Indian government over the interpretation of Section 3 (d) of the ...
- Pharma companies fear generics will erode their marginsIndian and foreign drug makers have already suffered heavy revenue loss due to changes in drug pricing or procurement policies in countries...
- Govt limits MNCs' supply of essential drugs on local buyForeign drug makers buying stake in Indian pharmaceutical companies will now be required to manufacture and supply essential medicines to t...
- Pharma companies open to milder alternative pricing mechanismThis will help allay government's fears of a spiraling of medicine prices if a market-based model, originally sought by the pharma companie...
- Local regulations keep foreign pharma companies on tenterhooksThe grant of the country's first compulsory drug licence and recent attempts at populist policy initiatives have raised fears of overseas p...
- Let pharma takeovers beSale of Indian drug companies to multinationals is a way of value creation for Indian entrepreneurs and investors.
- Ranbaxy to ink R&D deal with foreign coClose on the heels of striking a strategic alliance with domestic pharma company Orchid, Ranbaxy is close to signing a significant research...
Load More
